NSGO
About NSGO, The NSGO Board, Administration & Working Groups
The Story
The Nordic Society of Gynaecological Oncology was founded in November 1986 in Oslo, by representatives from Denmark, Finland, Norway, and Sweden. The purpose of the society was, and is still today, to advance communication between the Nordic countries in gynaecological cancer research between Doctors, Professors, Young Doctors and academic Study Nurses.
The Society has since accepted Iceland as a representative, though the population is low to be included in the statistics.
The Baltic Regions – Lithuania & Estonia are associate members of NSGO.
NSGO currently has over 300 members.
The Nordic countries alternate in hosting the NSGO Annual Meeting.
Mission
The society aims to enhance the prevention, diagnosis, treatment, and follow-up practices related to gynaecological cancer, while also promoting and supporting basic and clinical research in this field. Additionally, the society strives to foster education and training in all aspects of gynaecological oncology.
Our objective is to provide a platform for individual professionals who are devoted to the care of women with gynaecological cancer.
Furthermore, we encourage and facilitate Nordic and global collaboration and friendship among experts and organizations engaged in the field of gynaecological oncology.
Purpose
The Nordic Society of Gynaecological Oncology aims to foster cooperation and coordination among professionals in the field of gynaecological cancer.
We promote and conduct collaborative clinical trials while also organizing and coordinating conferences, meetings, and other collaborative activities.
We strive to establish better Nordic Standards of Care for women with gynaecological cancer and produce Nordic Guidelines for professional education and training in gynaecological oncology.
Furthermore, we engage in developing cooperation and relationships with other international, national, and regional organizations working in this field.
The Board of NSGO comprises regular members, with at least two representatives from each of the five Nordic Countries, Denmark, Finland, Iceland, Norway & Sweden.
The elected Board members serve for a two-year term and can be re-elected for an additional two-year term.
The President’s tenure is three years and does not allow for direct re-election.
The President-Elect also serves a three-year term. Upon completing their term as President-Elect, they automatically will assume the role of President.
The Board oversees & approves applications for the NSGO Research Grant.
President
Trine
Jakobi Nøttrup
Consultant, Phd
Rigshospitalet,
Copenhagen, Denmark
President-elect
Hanna
Dahlstrand
Senior Consultant, M.D.
Karolinska university hospital,
Stockholm, Sweden
Mikkel
Rosendahl
MD, PhD
Rigshospitalet,
Copenhagen, Denmark
Trine Lembrecht Jørgensen
Associate Professor
Odense Universitetshospital,
Odense, Denmark
Anniina
Färkkilä
CONSULTANT, MD
UNIVERSITY OF HELSINKI,
Helinski, Finland
Elina
Urpilainen
CONSULTANT, MD
OULU University Hospital,
Oulu, Finland
Bente
Vilming
Consultant, MD
RADIUM HOSPITAL,
Oslo, Norway
Trine
Stokstad
Associate professor
Trondheim University Hospital,
Trondheim, Norway
Camilla
Sköld
Senior Consultant, MD
Karolinska Institutet and Uppsala University, Sweden
Katja
Stenstrom Bohlin
MD, PHD
Karolinska University Hospital,
Stockholm, Sweden
Anne
Ahtikoski
Consultant, MD
Turku University Hospital,
Turku, Finland
Jan-Erik
Palmgren
Associate professor
Kuopio University Hospital,
Kuopio, Finland
The Nordic Society of Gynaecological Oncology nominating committee is responsible for identifying and proposing candidates for positions in the NSGO Board, including the President-Elect and Board members.
They consist of one representative from each of the Nordic countries.
Gabriel Lindahl
Chair
Sweden
Cecilie Torkildsen
Norway
Jacob Jóhannsson
Iceland
Lone Kjeld Petersen
Denmark
Maarit Antila
Finland
1986 - present day
Claes
Tropé
1986-1991
Kamma
Bertelsen
1992-1997
Gunnar
B. Kristensen
1998-2006
Bengt
Tholander
2006-2009
Elisabeth
Åvall Lundqvist
2009-2015
Johanna
Mäenpää
2015-2018
Annika
Auranen
2018-2021
Line
Bjørge
2021-2024
Address
Nordic Society of Gynaecological Oncology, Department of Cancer Treatment, 9431 Rigshospitalet Copenhagen University Hospital. Blegdamsvej 9 DK-2100, Copenhagen
Contact
Financial Department
Data Protection Officer
Office Phone
+45 3545 3389
Monday – Thursday 09.00 – 15.00
Firday 09.00 – 14.00